2. Search Result
Search Result
Results for "

α-GLU

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

2

Biochemical Assay Reagents

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N11598
    α-GLU

    		Others Metabolic Disease
    α-GLU stands for α-glucosidase. α-GLU hydrolyzes starch and disaccharides via targeting to terminal, non-reducing (1→4)-linked α-D-glucose residues to produce α-glucose. α-GLU is substrate selective .
    α-GLU
  • HY-149668
    α-Glucosidase-IN-41

    		Glucosidase Metabolic Disease
    α-Glucosidase-IN-41 (compound 5o) is a potent α-glucosidase inhibitor. α-Glucosidase-IN-41 can arise the changed secondary structure of α-Glu to hinder enzyme catalytic activity. α-Glucosidase-IN-41 can be used for diabetes mellitus research .
    α-Glucosidase-IN-41
  • HY-W280197
    5-Bromo-4-chloro-3-indolyl-α-D-glucopyranoside, 98%

    X-α-GLU, 98%

    		 Biochemical Assay Reagents Others
    5-Bromo-4-chloro-3-indolyl-α-D-glucopyranoside, 98% (X-α-Glu, 98%) is a biochemical assay reagent.
    5-Bromo-4-chloro-3-indolyl-α-D-glucopyranoside, 98%
  • HY-159477
    SARS-CoV-2-IN-92

    		SARS-CoV Infection Inflammation/Immunology
    SARS-CoV-2-IN-92 (compound 11) inhibits SARS-CoV-2 variants (EC50 = 0.48 μM), as well as SARS-CoV and MERS-CoV. SARS-CoV-2-IN-92 (compound 11) potently and selectively blocks ERα-Glu II .
    SARS-CoV-2-IN-92
  • HY-145275
    EB-0176

    		Glucosidase Infection
    EB-0176 is a potent inhibitor of ER α-glucosidases (α-Glu) Iand II with IC50s of 0.6439 and 0.0011 μM, respectively. EB-0176 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0176 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses .
    EB-0176
  • HY-145274
    EB-0156

    		Glucosidase Infection
    EB-0156 is a potent inhibitor of ER α-glucosidases (α-Glu) Iand II with IC50s of 0.0479 and less than 0.001 μM, respectively. EB-0156 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0156 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses .
    EB-0156
  • HY-145273
    EB-0150

    		Glucosidase Infection
    EB-0150 is a potent inhibitor of ER α-glucosidases (α-Glu) Iand II with IC50s of 0.73 and 0.0337 μM, respectively. EB-0150 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0150 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses . EB-0150 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
    EB-0150
  • HY-W747631
    Diethylene glycol monopentyl ether

    		Biochemical Assay Reagents Others
    5-Bromo-4-chloro-3-indolyl-α-D-glucopyranoside, 98% (X-α-Glu, 98%) is a biochemical assay reagent.
    Diethylene glycol monopentyl ether

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: